Hepatitis C is an infectious disease caused by Hepatitis C virus (HCV) and affects primarily the liver. Hepatitis C is commonly caused by blood to blood contacts such as intravenous drug use, unsterilized equipment and blood transfusions. Hepatitis C may also cause from mother to fetus during birth. People with alcoholism and HIV infection of any age group are at increased riskChanging aspects of global hepatitis C treatment market
The global Hepatitis C treatment market is boosting due to following factors-
• Increased cases and awareness about the HCV infection
• Government initiatives and various policies helping the cause
• Increasing fund in R & D activities
• New and innovative drug production
Though, absence of antibiotics, expensive medications, and dearth of hepatitis C infection awareness in underdeveloped countries can hamper the market growth of hepatitis C treatment globally.
Market summary:
According to the World Health Organization (WHO), there are 80 Mn people worldwide suffering from chronic hepatitis C virus (HCV),. Collaborations, acquisitions and mergers, new product launches, increase in R & D activities, and sanctions for new products from various drug regulatory bodies such as U.S. FDA are some key tactics followed by various businesses to boost their market growth in global Hepatitis C treatment market.
Read more Insights at [URL]https://www.precisionbusinessinsights.com/market-reports/global-hepatitis-c-treatment-market/[/URL]
Notable market development:
Mavyret (Glecaprevir/Pibrentasvir) by AbbVie received FDA approval in 2017 for treatment of chronic hepatitis C virus (HCV) infection in all major genotypes (GT1-6)
Some of the key players in the global Hepatitis C treatment market are
• GlaxoSmithKline, plc. (U.K.)
• Bristol-Myers Squibb (U.S)
• F. Hoffmann- La Roche Ltd. (Switzerland)
• Merck & Co, Inc. (U.S)
• Johnson & Johnson Services, Inc. (U.S.)
• Gilead Sciences (U.S.)
• AbbVie Inc. (U.S.)
• Vertex Pharmaceuticals Inc. (U.S.)
• Kadmon Holdings, Inc. (U.S.)
Avail sample report at [URL]https://bit.ly/2RUfDt3[/URL]
The global Hepatitis C treatment market is categorized on the basis of drug class, route of administration, end-users and geographical regions.
By drug class
• Polymerase Inhibitors
• NS5A Inhibitors
• Interferons
• HCV protease inhibitors
• Combination Therapy
By route of administration
• Oral
• Parenteral
By end-users
• Retail Pharmacies
• Hospital Pharmacies
• Others
By geographical regions
• North America
• Latin America
• Asia Pacific
• The Middle East and Africa
• Europe
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact us
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US):+1-866-598-1553
Website @https://www.precisionbusinessinsights.com